Genmab — November 2020

[Sukkeralf]

So not the 4-1BB week I´d imagined so far - so hard to judge these early data. Looking forward to the explanations on CMD

[E_L]

Well, this early it is all about safety, and longer data hardly changed from what we already saw, so that is a +

[E_L]

●   Most AEs were mild to moderate; treatment-related Grade 3 transaminase elevations resolved with corticosteroids.

–   No treatment-related bilirubin increases or Grade 4 transaminase elevations were observed.

[JørgenVarnæs]

Mon det er de 2 opgørelser med 65,6% SD/PR og ORR=11-33%, der forvirrer begreberne?

[E_L]

i think that is important, if liver toxicity can be handled

[JørgenVarnæs]

Når vi er så langt henne i sygdomsforløbet bliver man nødt til at kigge alvorligt på SD tallene også (IMO)

[E_L]

agree, specially since most of them are not yet on the highest dose

[E_L]

it doesn't say at what dose the NSCLC expansian is, does it?

[JørgenVarnæs]

Men jeg vil ikke lægge alt for meget vægt på orr endnu - dertil er antallet af patienter for småt. Men det er jo gætværk vi er ude i her - så måske med n=30 vi har et solidt fingerpeg

[Bulder]

Ja, umiddelbart falder man jo ikke ned af stolen. Men måske kan man ikke forvente mere af så syge pts.

[Bulder]

Kan godt være at SD i virkeligheden er udmærket.

[E_L]

Not sure what you guys all expected to get, but this is a PhI dose escalation. MTD not reached, safety acceptable. and at these dose it shows efficacy. SD for patients like this is unfortunately already a big +

[E_L]

my next questoin is, can the dose still go up? will the open expansion cohorts for the other diseases? they initially enrolled most in colorectal; will it proceed?

[E_L]

On December 8 at 12:30 PM EST (6:30 PM CET / 5:30 PM GMT) Genmab will hold its virtual 2020 ASH Data Review and present its 2021 Key Priorities.

[DevOp]

If efficacy is also shown in the NSCLC pts already treated with ICI, that looks like a proof of concept

[JørgenVarnæs]

Jeg kan ikke finde nogen opdelinger af dose/indikation i dokumentet. Der er dog kun n=4 på højeste dose

[E_L]

I think Fig 6 shows the dose per patient below each patient, but i can not read that... Fig 7 also

[AaBforever]

Spændende hvor langt vi skal ned på nyhederne..:-(...måske har JvdW været for entusiastisk.

[E_L]

or maybe people don't think for themselves , start whining when the price goes down and blame that on data they don't understand

[Helge_LarsenPI-redaktør]